End of this week

http://www.reuters.com/article/2014/04/14/il-akorn-hi-tech-pharma-idUSnBw146433a+100+BSW20140414

 

WASHINGTON, April 14 (Reuters) - Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, the Federal Trade Commission said on Monday.

The deal, which is valued at $640 million, will allow Akorn to expand its eye drug portfolio to oral liquids and ointments.

The divested assets will be sold to Watson Laboratories, a subsidiary of Watson Pharmaceuticals, which changed its name to Actavis PLC last year.

The divested products are generic Ciloxan eye drops, used to treat bacterial eye infections and corneal ulcers; generic Quixin drops, and a generic ointment used to treat bacterial eye infections. Akorn also agreed to divest two prescription topical anesthetics, Xylocaine and EMLA. (Reporting by Diane Bartz; Editing by Sandra Maler and Jim Loney)

 

And thus starts the "six month" clock.

 

Exactly! Akorn, clearly isn't interested in any segment outside of their niche market. Bye-bye ECR.

 

Agree but it will be less than 6 months.

 

NEW YORK, April 15, 2014 /PRNewswire/ -- Repligen Corporation (RGEN) will replace Hi-Tech Pharmacal Co., Inc. (HITK) in the S&P SmallCap 600 after the close of trading on Thursday, April 17. S&P SmallCap 600 constituent Akorn Inc. (AKRX) is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Headquartered in Waltham, MA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Biotechnology Sub-Industry index.

 

http://online.wsj.com/article/PR-CO-20140417-908511.html

The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player. Hmmmm ... doesn't look good for us.

 

Watson became huge selling generics and branded generics. Seems to have worked for them

 

The salary & joke of a commission, this company pays is Absolutely INSULTING!

 

management

Another insult is having a MANAGER (DA) tell you NOT to call him because he's going to be hungover & doesn't want any reps calling him.Who hired the i****? Couldn't manage a turd down a toilet

 

Re: management

Maybe he doesn't like you. I know for a fact he didn't tell his team not to call. Maybe you are just striking out and kicking a person when they are down because you are a pathetic excuse for a human being. Look im sorry your mommy thinks you are a douche bag. But is it really that hard to see why? Grow up.